Income Statement - Keros Therapeutics, Inc. (KROS)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 244.06 | 3.55 | 0.15 | 20.00 | 20.10 | 2.50 | 10.00 | 10.00 |
| Cost of revenue | 1.51 | 1.23 | 0.82 | 1.62 | 0.90 | 0.61 | 17.35 | 10.11 |
| Gross profit | 242.55 | 3.55 | 0.15 | -1.62 | 20.10 | -0.61 | -7.35 | -0.11 |
| Total operating expenses | 171.93 | 214.38 | 170.09 | 114.79 | 76.47 | 46.05 | 20.01 | 11.32 |
| Operating income | 70.62 | -210.83 | -169.94 | -114.79 | -56.37 | -46.66 | -10.56 | -1.69 |
| Non-operating income (net) | 21.27 | 23.78 | 16.95 | 10.11 | -0.36 | 1.12 | -1.77 | 0.61 |
| Income before tax | 91.90 | -187.05 | -152.99 | -104.68 | -56.73 | -45.53 | -12.34 | -1.08 |
| Income tax expense | 4.88 | 0.30 | -0.21 | 0.00 | 2.01 | -0.17 | 0.01 | 0.26 |
| Net income | 87.01 | -187.35 | -152.99 | -104.68 | -58.74 | -45.36 | -12.34 | -1.34 |
Show Quarterly Income Statement
Income Statement - Keros Therapeutics, Inc. (KROS)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.37 | 0.39 | 14.26 | 18.17 | 211.25 | 3.04 | 0.39 | 0.04 | 0.08 | 0.14 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 20.00 | 0.00 | 0.10 | 0.00 | 0.00 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
| Cost of revenue | 0.40 | 0.40 | 0.40 | 0.37 | 0.34 | 0.33 | 0.31 | 0.31 | 0.28 | 0.25 | 0.55 | 0.55 | 0.69 | 0.45 | 0.34 | 0.51 | 0.32 | 0.30 | 0.22 | 9.98 | 0.18 | 9.67 | 8.40 | 7.26 | 8.53 | 4.13 | 3.85 | 4.50 | 4.87 |
| Gross profit | -0.04 | 0.39 | 13.87 | 17.80 | 211.25 | 2.71 | 0.07 | 0.04 | 0.08 | 0.14 | -0.54 | -0.55 | -0.69 | -0.45 | -0.34 | -0.41 | -0.32 | 19.70 | -0.22 | -9.88 | -0.18 | -9.67 | -5.90 | -4.76 | -6.03 | -1.63 | -1.35 | -2.00 | -2.37 |
| Total operating expenses | 25.84 | 29.66 | 29.25 | 57.62 | 59.21 | 55.96 | 58.73 | 50.48 | 48.57 | 46.60 | 42.74 | 41.34 | 38.87 | 31.96 | 27.98 | 30.73 | 24.13 | 24.56 | 20.20 | 5.66 | 15.77 | 13.29 | 11.95 | 10.91 | 10.50 | 5.23 | 4.83 | 5.15 | 5.36 |
| Operating income | -25.88 | -29.27 | -15.38 | -39.82 | 152.04 | -53.25 | -58.66 | -50.44 | -48.48 | -46.46 | -43.28 | -41.34 | -38.87 | -31.96 | -27.98 | -30.73 | -24.13 | -4.87 | -20.20 | -15.54 | -15.77 | -13.29 | -11.95 | -10.91 | -10.50 | -2.73 | -2.33 | -2.65 | -2.86 |
| Non-operating income (net) | 2.17 | 4.30 | 6.68 | 6.90 | 6.45 | 7.53 | 5.70 | 5.18 | 5.37 | 6.21 | 3.84 | 3.83 | 3.07 | 2.24 | 4.47 | 3.46 | -0.06 | -0.08 | -0.14 | -0.08 | -0.07 | 2.62 | -0.09 | 0.16 | -1.56 | -0.02 | -1.22 | -0.20 | -0.33 |
| Income before tax | -23.71 | -24.98 | -8.70 | -32.92 | 158.49 | -45.73 | -52.96 | -45.26 | -43.11 | -40.24 | -39.44 | -37.51 | -35.80 | -29.72 | -23.51 | -27.27 | -24.19 | -4.94 | -20.34 | -15.62 | -15.84 | -10.68 | -12.04 | -10.76 | -12.06 | -2.75 | -3.55 | -2.85 | -3.18 |
| Income tax expense | -1.51 | -1.42 | -2.22 | 10.04 | 0.30 | -0.28 | 3.81 | -0.21 | 3.83 | -3.07 | 0.00 | -4.47 | -3.46 | 0.00 | 2.00 | -0.04 | -0.08 | 0.05 | 0.08 | -0.16 | 0.00 | -0.17 | 2.30 | -1.22 | 0.00 | 0.00 | |||
| Net income | -23.71 | -23.46 | -7.28 | -30.70 | 148.45 | -46.03 | -52.96 | -45.26 | -43.11 | -40.24 | -39.44 | -37.51 | -35.80 | -29.72 | -23.51 | -27.27 | -24.19 | -6.94 | -20.30 | -15.62 | -15.89 | -10.68 | -12.04 | -10.76 | -11.89 | -2.75 | -3.55 | -2.85 | -3.18 |